| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 27,109 | 12,336 | 6,864 | | Selling General and Administrative | 5,288 | 4,169 | 2,670 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (32,397) | (16,505) | (9,534) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,684) | 1,424 | 863 | | Earnings Before Interest And Taxes | (35,081) | (15,082) | (8,671) | | Interest Expense | 5 |
-
|
-
| | Income Before Tax | (35,086) | (15,082) | (8,671) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (35,086) | (15,082) | (8,671) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (35,086) | (15,082) | (8,671) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($35,086) | ($15,082) | ($8,671) |
|
0.29% Nasdaq 
Income Statement
